EGFR Mutations Year 10 Three New Drugs Emerge - Are we Closer to Cure-94935_slide_ppt.pdf

EGFR Mutations Year 10 Three New Drugs Emerge - Are we Closer to Cure-94935_slide_ppt.pdf

ID:34854784

大小:2.65 MB

页数:33页

时间:2019-03-12

EGFR Mutations Year 10 Three New Drugs Emerge - Are we Closer to Cure-94935_slide_ppt.pdf_第1页
EGFR Mutations Year 10 Three New Drugs Emerge - Are we Closer to Cure-94935_slide_ppt.pdf_第2页
EGFR Mutations Year 10 Three New Drugs Emerge - Are we Closer to Cure-94935_slide_ppt.pdf_第3页
EGFR Mutations Year 10 Three New Drugs Emerge - Are we Closer to Cure-94935_slide_ppt.pdf_第4页
EGFR Mutations Year 10 Three New Drugs Emerge - Are we Closer to Cure-94935_slide_ppt.pdf_第5页
资源描述:

《EGFR Mutations Year 10 Three New Drugs Emerge - Are we Closer to Cure-94935_slide_ppt.pdf》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、EGFRMutationsYear10
ThreeNewDrugsEmerge-
AreweClosertoCure?

PresentedByThomasLynchat2014ASCOAnnualMeetingSlide2PresentedByThomasLynchat2014ASCOAnnualMeetingSlide3PresentedByThomasLynchat2014ASCOAnnualMeetingProgression-freesurvivalinEGFRmutation

2、r/>positiveandnegativepatientsPresentedByThomasLynchat2014ASCOAnnualMeetingSelectedTrialsofTKI1stLineEGFRMutationPositiveNSCLCPresentedByThomasLynchat2014ASCOAnnualMeetingSlide6PresentedByThomasLynchat2014ASCOAnnualMeetingCanwemake1stGenTKIBetter?PresentedByThomas

3、Lynchat2014ASCOAnnualMeetingPhaseIbstudyofAfatinib&CetuximabPresentedByThomasLynchat2014ASCOAnnualMeetingTumorRegressionbyT790MMutationStatus
atRecommendedDosePresentedByThomasLynchat2014ASCOAnnualMeetingCetux/AfatanibToxicityPresentedByThomasLynchat2014ASCOAn

4、nualMeetingSlide11PresentedByThomasLynchat2014ASCOAnnualMeetingNextGenEGFRTKIs:MutantSpecificAgentsEmergePresentedByThomasLynchat2014ASCOAnnualMeetingHM61713PresentedByThomasLynchat2014ASCOAnnualMeetingHM61713PresentedByThomasLynchat2014ASCOAnnualMeetingHM61713Pre

5、sentedByThomasLynchat2014ASCOAnnualMeetingCO-1686PresentedByThomasLynchat2014ASCOAnnualMeetingCO-1686PresentedByThomasLynchat2014ASCOAnnualMeetingCO-1686PresentedByThomasLynchat2014ASCOAnnualMeetingProgression-freesurvival(K-Mestimate)PresentedByThomasLynchat2014A

6、SCOAnnualMeetingAZD9291PresentedByThomasLynchat2014ASCOAnnualMeetingAZD9291PresentedByThomasLynchat2014ASCOAnnualMeetingAZD9291PresentedByThomasLynchat2014ASCOAnnualMeetingResponserate*accordingtoT790M(centraltest)status:immediatepriorEGFR-TKI,#yesvsnoPresentedByT

7、homasLynchat2014ASCOAnnualMeetingHaveweimprovedRx?PresentedByThomasLynchat2014ASCOAnnualMeetingPreliminaryEfficacyComparisonPresentedByThomasLynchat2014ASCOAnnualMeetingToxicityComparisonPresentedByThomasLynchat2014ASCOAnnualMeetingConclusionsPresentedByThomasLync

8、hat2014ASCOAnnualMeetingConclusionsPresentedByThomasLynchat2014ASCOAnnualMeetingConclusionsPresentedByThomasLynchat2014ASCOAnnualMeetingSlide30Presented

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。